The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis
Open accessAbstract
Abstract Rationale Sputum neutrophil elastase and serum desmosine, which is a linked marker of endogenous elastin degradation, are possible biomarkers of disease severity and progression in bronchiectasis. This study aimed to determine the association of elastase activity and desmosine with exacerbations and lung function decline in bronchiectasis. Methods This was a single-center prospective cohort study using the TAYBRIDGE (Tayside Bronchiectasis Registry Integrating Datasets, Genomics, and Enrolment into Clinical Trials) registry in Dundee, UK. A total of 433 patients with high-resolution computed tomography–confirmed bronchiectasis provided blood samples for desmosine measurement, and 381 provided sputum for baseline elastase activity measurements using an activity-based immunosassay and fluorometric substrate assay. Candidate biomarkers were tested for their relationship with cross-sectional markers of disease severity, and with future exacerbations, mortality and lung function decline over 3 years. Measurement and Main Results Elastase activity in sputum was associated with the bronchiectasis severity index (r = 0.49; P < 0.0001) and was also correlated with the Medical Research Council dyspnea score (r = 0.34; P < 0.0001), FEV1% predicted (r = −0.33; P < 0.0001), and the radiological extent of bronchiectasis (r = 0.29; P < 0.0001). During a 3-year follow-up, elevated sputum elastase activity was associated with a higher frequency of exacerbations (P < 0.0001) but was not independently associated with mortality. Sputum elastase activity was independently associated with FEV1 decline (β coefficient, −0.139; P = 0.001). Elastase showed good discrimination for severe exacerbations with an area under the curve of 0.75 (95% confidence interval [CI], 0.72–0.79) and all-cause mortality (area under the curve, 0.70; 95% CI, 0.67–0.73). Sputum elastase activity increased at exacerbations (P = 0.001) and was responsive to treatment with antibiotics. Desmosine was correlated with sputum elastase (r = 0.42; P < 0.0001) and was associated with risk of severe exacerbations (hazard ratio 2.7; 95% CI, 1.42–5.29; P = 0.003) but not lung function decline. Conclusions Sputum neutrophil elastase activity is a biomarker of disease severity and future risk in adults with bronchiectasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613 · cited 1×
“This study was conducted and is reported according to Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (18).”
MethodMeijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
Papayannopoulos, V., Metzler, K. D., Hakkim, A., & Zychlinsky, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201006052 · Cited by 2,103
The bronchiectasis severity index. An international derivation and validation study
Chalmers, J. D., Goeminne, P., Aliberti, S., McDonnell, M. J., Lonni, S., Davidson, J., Poppelwell, L., Salih, W., Pesci, A., Dupont, L. J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1575oc · Cited by 1,093
Self-citationBritish Thoracic Society guideline for non-CFbronchiectasis
Pasteur, M. C., Bilton, D., Hill, A. T., & on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136119 · Cited by 1,046
Risk Factors for Bronchiectasis in Children with Cystic Fibrosis
Sly, P. D., Gangell, C. L., Chen, L., Ware, R. S., Ranganathan, S., Mott, L. S., Murray, C. P., & Stick, S. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301725 · Cited by 595
Chalmers, J. D., Smith, M. P., McHugh, B. J., Doherty, C., Govan, J. R., & Hill, A. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0487oc · Cited by 410
Self-citationReiff, D. B., Wells, A. U., Carr, D. H., Cole, P. J., & Hansell, D. M. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.165.2.7618537 · Cited by 398
Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13572 · Cited by 373
Finch, S., McDonnell, M. J., Abo-Leyah, H., Aliberti, S., & Chalmers, J. D. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201506-333oc · Cited by 343
Self-citationEtiology of Non–Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity
Lonni, S., Chalmers, J. D., Goeminne, P. C., McDonnell, M. J., Dimakou, K., De Soyza, A., Polverino, E., Van de Kerkhove, C., Rutherford, R., Davison, J., et al. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201507-472oc · Cited by 327
Self-citationVandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213572 · Cited by 327
Amitani, R., Wilson, R., Rutman, A., Read, R., Ward, C., Burnett, D., Stockley, R. A., & Cole, P. J. (1991) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/4.1.26 · Cited by 305
A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis
Murray, M. P., Govan, J. R. W., Doherty, C. J., Simpson, A. J., Wilkinson, T. S., Chalmers, J. D., Greening, A. P., Haslett, C., & Hill, A. T. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201005-0756oc · Cited by 297
Self-citationTosi, M. F., Zakem, H., & Berger, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114699 · Cited by 289
British Thoracic Society guideline for non-CF bronchiectasis
Pasteur, M. C., Bilton, D., Hill, A. T., & on behalf of the British Thoracic Society Non-CF Bronchiectasis Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.142778 · Cited by 287
Management of bronchiectasis in adults
Chalmers, J. D., Aliberti, S., & Blasi, F. (2015) · European Respiratory Journal · doi:10.1183/09031936.00119114 · Cited by 286
Self-citationNeutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells
Voynow, J. A., Young, L. R., Wang, Y., Horger, T., Rose, M. C., & Fischer, B. M. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.5.l835 · Cited by 280
Clinical phenotypes in adult patients with bronchiectasis
Aliberti, S., Lonni, S., Dore, S., McDonnell, M. J., Goeminne, P. C., Dimakou, K., Fardon, T. C., Rutherford, R., Pesci, A., Restrepo, M. I., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01899-2015 · Cited by 277
Self-citationSputum Biomarkers of Inflammation and Lung Function Decline in Children with Cystic Fibrosis
Sagel, S. D., Wagner, B. D., Anthony, M. M., Emmett, P., & Zemanick, E. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0507oc · Cited by 242
Association between Pulmonary Function and Sputum Biomarkers in Cystic Fibrosis
Mayer-Hamblett, N., Aitken, M. L., Accurso, F. J., Kronmal, R. A., Konstan, M. W., Burns, J. L., Sagel, S. D., & Ramsey, B. W. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1354oc · Cited by 226
Quittner, A. L., O'Donnell, A. E., Salathe, M. A., Lewis, S. A., Li, X., Montgomery, A. B., O'Riordan, T. G., & Barker, A. F. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-205918 · Cited by 219
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Fuschillo, S., De Felice, A., & Balzano, G. (2008) · European Respiratory Journal · doi:10.1183/09031936.00069007 · Cited by 219
Phase II study of a neutrophil elastase inhibitor (AZD9668) in patients with bronchiectasis
Stockley, R., De Soyza, A., Gunawardena, K., Perrett, J., Forsman-Semb, K., Entwistle, N., & Snell, N. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2012.12.009 · Cited by 201
Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis
Chalmers, J. D., & Hill, A. T. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.09.011 · Cited by 200
Self-citationMiller, B. E., Tal‐Singer, R., Rennard, S. I., Furtwaengler, A., Leidy, N. K., Lowings, M., Martin, U. J., Martin, T. R., Merrill, D. D., Snyder, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1722pp · Cited by 148
Woolhouse, I., Bayley, D. L., & Stockley, R. A. (2002) · Thorax · doi:10.1136/thorax.57.8.667 · Cited by 130
Dubois, A. V., Gauthier, A., Bréa, D., Varaigne, F., Diot, P., Gauthier, F., & Attucci, S. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0380oc · Cited by 109
Taylor, S., Rogers, G. B., Chen, A. C. –., Burr, L. D., McGuckin, M. A., & Serisier, D. J. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201411-513oc · Cited by 100
The role of neutrophils in cystic fibrosis
Gifford, A., & Chalmers, J. D. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000009 · Cited by 98
Self-citationDente, F. L., Bilotta, M., Bartoli, M. L., Bacci, E., Cianchetti, S., Latorre, M., Malagrinò, L., Nieri, D., Roggi, M. A., Vagaggini, B., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/642503 · Cited by 94
Rabinovich, R., Miller, B. E., Wrobel, K., Ranjit, K., Williams, M. C., Drost, E., Edwards, L. D., Lomas, D. A., Rennard, S. I., Agustí, A. G. N., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01824-2015 · Cited by 80
Self-citationGoeminne, P., Vandooren, J., Moelants, E. A. V., Decraene, A., Rabaey, E., Pauwels, A., Seys, S., Opdenakker, G., Proost, P., & Dupont, L. (2013) · Respirology · doi:10.1111/resp.12219 · Cited by 69
Sputum Sol Neutrophil Elastase Activity in Bronchiectasis
Chan, S., Shum, D. K., & Ip, M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-829oc · Cited by 65
Human Neutrophil Peptides and Phagocytic Deficiency in Bronchiectatic Lungs
Voglis, S., Quinn, K. L., Tullis, E. D., Liu, M., Henriques, M., Zubrinich, C. M., Peñuelas, Ó., Chan, H., Silverman, F., Cherepanov, V., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1250oc · Cited by 56
Guan, W., Gao, Y., Xu, G., Lin, Z., Tang, Y., Gu, Y., Liu, G., Li, H., Chen, R., & Zhong, N. (2015) · Respirology · doi:10.1111/resp.12582 · Cited by 41
Challenges in the development of new therapies for bronchiectasis
Chalmers, J. D., Loebinger, M. R., & Aliberti, S. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1019863 · Cited by 26
Self-citationAdult Non-Cystic Fibrosis Bronchiectasis Is Characterised by Airway Luminal Th17 Pathway Activation
Chen, A. C. –., Martin, M. L., Lourie, R., Rogers, G. B., Burr, L. D., Hasnain, S. Z., Bowler, S., McGuckin, M. A., & Serisier, D. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119325 · Cited by 24
Guan, W., Gao, Y., Xu, G., Lin, Z., Tang, Y., Li, H.-M., Li, Z., Zheng, J.-P., Chen, R., & Zhong, N. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.04.04 · Cited by 20
Cited by
European Respiratory Society guidelines for the management of adult bronchiectasis
Polverino, E., Goeminne, P. C., McDonnell, M. J., Aliberti, S., Marshall, S. E., Loebinger, M. R., Murris, M., Cantón, R., Torres, A., Dimakou, K., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00629-2017 · Cited by 1,333
Self-citationAdvances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
Flume, P. A., Chalmers, J. D., & Olivier, K. N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31767-7 · Cited by 545
Self-citationLung microbiome: new insights into the pathogenesis of respiratory diseases
Li, R., Li, J., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01722-y · Cited by 434
Muco-Obstructive Lung Diseases
Boucher, R. C. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1813799 · Cited by 398
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
Chalmers, J. D., Haworth, C. S., Metersky, M. L., Loebinger, M. R., Blasi, F., Sibila, O., O’Donnell, A. E., Sullivan, E. J., Mange, K. C., Fernandez, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021713 · Cited by 377
Self-citation
Metadata
- Authors
- Chalmers, J. D., Moffitt, K. L., Suarez-Cuartin, G., Sibila, O., Finch, S., Furrie, E., Dicker, A., Wrobel, K., Elborn, J. S., Walker, B., Martin, S. L., Marshall, S. E., Huang, J. T.-J., & Fardon, T. C.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-15
- Volume
- 195
- Issue
- 10
- Pages
- 1384-1393
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2560738370
- Cited by
- 416
- References
- 40
- FWCI
- 24.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.